Explore

AP News AP News
Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus
Trendline Trendline
Nielsen BioSciences Reports Successful Phase 3 Trial of CANDIN for Wart Treatment

Nielsen BioSciences Reports Successful Phase 3 Trial of CANDIN for Wart Treatment

Nielsen BioSciences Reports Successful Phase 3 Trial of CANDIN for Wart Treatment
Trendline Trendline
Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment

Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment

Nielsen BioSciences Completes Successful Phase 3 Trial for CANDIN in Wart Treatment
Trendline Trendline
Biopharma Companies Explore PD-(L)1×VEGF Bispecifics Beyond Lung Cancer

Biopharma Companies Explore PD-(L)1×VEGF Bispecifics Beyond Lung Cancer

Biopharma Companies Explore PD-(L)1×VEGF Bispecifics Beyond Lung Cancer
Trendline Trendline
Precision BioSciences Reports Breakthrough in Hepatitis B Treatment with PBGENE-HBV

Precision BioSciences Reports Breakthrough in Hepatitis B Treatment with PBGENE-HBV

Precision BioSciences Reports Breakthrough in Hepatitis B Treatment with PBGENE-HBV
Discover daily Discover daily
How did Mixed Martial Arts Evolve Over Time

How did Mixed Martial Arts Evolve Over Time

Mixed martial arts (MMA) is a dynamic and evolving sport that combines techniques from various martial arts and combat sports. Its journey from anc...
Trendline Trendline
Antengene Initiates Phase III Study for ATG-022 in Advanced Gastric Cancer

Antengene Initiates Phase III Study for ATG-022 in Advanced Gastric Cancer

Antengene Initiates Phase III Study for ATG-022 in Advanced Gastric Cancer
Trendline Trendline
Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval
Trendline Trendline
PharmaEssentia Appoints Eric Vogel as U.S. Head of Commercialization for BESREMi Expansion

PharmaEssentia Appoints Eric Vogel as U.S. Head of Commercialization for BESREMi Expansion

PharmaEssentia Appoints Eric Vogel as U.S. Head of Commercialization for BESREMi Expansion
Trendline Trendline
Brenus Pharma's STC-1010 Receives FDA IND Approval for Colorectal Cancer

Brenus Pharma's STC-1010 Receives FDA IND Approval for Colorectal Cancer

Brenus Pharma's STC-1010 Receives FDA IND Approval for Colorectal Cancer
Trendline Trendline
Merz Therapeutics and Kvvit Partner to Expand Parkinson's Treatment in Greater China

Merz Therapeutics and Kvvit Partner to Expand Parkinson's Treatment in Greater China

Merz Therapeutics and Kvvit Partner to Expand Parkinson's Treatment in Greater China
Trendline Trendline
Precision BioSciences Unveils Breakthrough Data on Hepatitis B Treatment at EASL Congress

Precision BioSciences Unveils Breakthrough Data on Hepatitis B Treatment at EASL Congress

Precision BioSciences Unveils Breakthrough Data on Hepatitis B Treatment at EASL Congress